Inserm Company Profile

10:55 EDT 23rd March 2018 | BioPortfolio



101 rue de Tolbiac


Phone: 33 (0)1 44 23 60 00
Fax: 33 (0)1 45 85 68 56

News Articles [17 Associated News Articles listed on BioPortfolio]

Zika: An accurate estimation of the neurological risks in unborn children

(INSERM (Institut national de la santé et de la recherche médicale)) Thanks to a study conducted in pregnant women and their unborn children during the Zika epidemic in the French territories in the...

Genisphere and INSERM partner to develop neurological nanotherapies

Mutabilis joins European project supporting antiobiotics research

France's Mutabilis, a spinout from INSERM focused on new antibiotics, has announced it is participating…

Scientists develop technology to study blood vessel formation

A team of researchers at the Institute of Industrial Science (IIS), the University of Tokyo, CNRS and INSERM has developed a new organ-on-a-chip technology to study blood vessel formation and the drug...

Step Pharma closes €14.5mm Series A round

Step Pharma (developing immune disease therapeutics) raised €14.5mm ($17mm) through a two-tranche Series A round. Participants included new investor Pontifax and returning backers Kurma Partners (le...

New organ-on-a-chip technology provides simple setting to study blood vessel formation

Researchers at the Institute of Industrial Science, the University of Tokyo, CNRS and INSERM, report a new organ-on-a-chip technology for the study of blood vessel formation and drugs targeting this e...

Chaperones can hold protein in non-equilibrium states

(Ecole Polytechnique Fédérale de Lausanne) Chaperones are specialized proteins in the cell that help other proteins to reach their functional 3-D shapes, which correspond to the states preferred at ...

Scientists discover five new regions of the genome that increase asthma risk

An international study led by scientists from Inserm and Paris Diderot Universit, the University of Chicago, the National Heart and Lung Institute and the University of Colorado Anschutz Medical Campu...

Drugs and Medications [0 Results]


PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Pharmacology and drug development in rare diseases: the attractiveness and expertise of the French medical pharmacology.

Developing drugs for rare disease can be challenging due to specific rare disease characteristics. The French Medical Pharmacology is structured and positioned to play a major role in Orphan Drug Rese...

KNOTTIN: the database of inhibitor cystine knot scaffold after 10 years, toward a systematic structure modeling.

Knottins, or inhibitor cystine knots (ICKs), are ultra-stable miniproteins with multiple applications in drug design and medical imaging. These widespread and functionally diverse proteins are charact...

Clinical Trials [23 Associated Clinical Trials listed on BioPortfolio]

Immunological Consequences of CARD15/NOD2 Mutations in Crohn's Disease

The project is based on adult and paediatric cohorts among the largest ones in Paris and located at Saint Louis and Robert Debré hospitals. Experiments will be performed at INSERM Unit U8...

Search for New Genetic Mutations Major Effect in Crohn's Disease

This study highlight genetics mutations with major effect in Crohn's Disease (CD) by WES in individuals affected and healthy individuals from EPIMAD Inserm InVS registry families.

Study of Covalently Closed Circular DNA (cccDNA) in Liver Transplant Patients With B Virus Markers

The aim of this study is to validate in the context of liver transplantation, the interest of the cccDNA assay technique developed by the team of Professor Zoulim (INSERM U1052) on liver b...

Biomechanical and Ultrasonic Assessment of the Achilles Tendon in Vivo (MEDUSAA)

Among Musculoskeletal disorders (MSD) the rupture of the Achilles tendon is the most common. Up today, the mechanical and elastic properties of the Achilles tendon are still unknown, and t...

Following of Atmospheric Pollution Exposure During Pregnancy and Effects on Health

The SEPAGES couple-child cohort is coordinated by an Inserm (French National Institute of Health and Medical Research) team of environmental epidemiology. SEPAGES cohort is based on the ge...

Companies [15 Associated Companies listed on BioPortfolio]

Annapurna Therapeutics and Weill Cornell Medicine

Annapurna Therapeutics, headquartered in Paris, is a privately held company dedicated to advancing gene therapy for significant unmet medical needs. It is funded by Versant Ventur...



TcLand S.A.

Founded in 2002 as a spin-off of INSERM U643/ITERT, one of the first research and transplantation centers in the world, and initially supported by the local incubator Atlanpole, TcLand is a biopharmac...


Spun off from Inserm (the French institute of health and medical research) in 2009, Sensorion is a biotech that specializes in the treatment of pathologies of the inner ear such a...

Laennec Tek

Laennec Tek is an independent CRO devoted to develop and implement innovative preclinical tests for drug discovery and safety pharmacology. The compagny was founded by Denis ESCANDE MD, PhD in februar...

More Information about "Inserm" on BioPortfolio

We have published hundreds of Inserm news stories on BioPortfolio along with dozens of Inserm Clinical Trials and PubMed Articles about Inserm for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Inserm Companies in our database. You can also find out about relevant Inserm Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record